Structurally unique GLP-1-based medicines that achieve substantially greater and rapid weight loss may impact musculoskeletal health, providing a rationale for therapeutics that more selectively target adipose tissue loss while preserving muscle mass and strength
GHK-Cu is a copper-binding tripeptide composed of glycine, histidine, and lysine bound to a copper(II) ion
Using expired or contaminated water increases the risk of infection and poor injection outcomes
Scenesse is available as subcutaneous implants, which provide more favorable pharmacokinetics than regular injections [4]
These medications are used to treat type 2 diabetes and obesity
Patients undergoing combined therapy should be carefully monitored for muscle pain, tenderness, or weakness, particularly in the early months of treatment or during periods of upward dose titration of either drug